Vernakalant versus electrical cardioversion in recent-onset atrial fibrillation

被引:10
作者
Conde, Diego [1 ]
Lalor, Nicolas [2 ]
Rodriguez, Leandro [2 ]
Elissamburu, Pablo [2 ]
Trivi, Marcelo [2 ]
机构
[1] Inst Cardiovasc Buenos Aires, Cardiovasc Emergency Care Sect, Sanat Anchorena, Buenos Aires, DF, Argentina
[2] Inst Cardiovasc Buenos Aires, Clin Cardiol Serv, Sanat Anchorena, Buenos Aires, DF, Argentina
关键词
Atrial fibrillation; Vernakalant; Electrical cardioversion; CONTROLLED-TRIAL; CONVERSION;
D O I
10.1016/j.ijcard.2013.06.055
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:4431 / 4432
页数:3
相关论文
共 8 条
  • [1] A Randomized Active-Controlled Study Comparing the Efficacy and Safety of Vernakalant to Amiodarone in Recent-Onset Atrial Fibrillation
    Camm, A. John
    Capucci, Alessandro
    Hohnloser, Stefan H.
    Torp-Pedersen, Christian
    Van Gelder, Isabelle C.
    Mangal, Brian
    Beatch, Gregory
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (03) : 313 - 321
  • [2] Vernakalant: Perception of state of health in patients with a recent-onset atrial fibrillation
    Conde, Diego
    Costabel, Juan Pablo
    Aragon, Martin
    Lambardi, Florencia
    Trivi, Marcelo
    [J]. CARDIOLOGY JOURNAL, 2014, 21 (03) : 304 - 308
  • [3] Propafenone Versus Vernakalant for Conversion of Recent-Onset Atrial Fibrillation
    Conde, Diego
    Pablo Costabel, Juan
    Aragon, Martin
    Lambardi, Florencia
    Klein, Andres
    Corrales Barbosa, Andrea
    Trivi, Marcelo
    Giniger, Alberto
    [J]. CARDIOVASCULAR THERAPEUTICS, 2013, 31 (06) : 377 - 380
  • [4] Flecainide versus vernakalant for conversion of recent-onset atrial fibrillation
    Conde, Diego
    Pablo Costabel, Juan
    Caro, Milagros
    Ferro, Alejandra
    Lambardi, Florencia
    Corrales Barboza, Andrea
    Lavalle Cobo, Augusto
    Trivi, Marcelo
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (03) : 2423 - 2425
  • [5] Conversion of recent onset atrial fibrillation: which drug is faster?
    Conde, Diego
    [J]. AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2013, 31 (09) : 1410 - 1411
  • [6] Vernakalant Hydrochloride for the Rapid Conversion of Atrial Fibrillation After Cardiac Surgery A Randomized, Double-Blind, Placebo-Controlled Trial
    Kowey, Peter R.
    Dorian, Paul
    Mitchell, L. Brent
    Pratt, Craig M.
    Roy, Denis
    Schwartz, Peter J.
    Sadowski, Jerzy
    Sobczyk, Dorota
    Bochenek, Andrzej
    Toft, Egon
    [J]. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2009, 2 (06) : 652 - 659
  • [7] A randomized, controlled trial of RSD1235, a novel anti-arrhythmic agent, in the treatment of recent onset atrial fibrillation
    Roy, D
    Rowe, BH
    Stiell, IG
    Coutu, B
    Ip, JH
    Phaneuf, D
    Lee, J
    Vidaillet, H
    Dickinson, G
    Grant, S
    Ezrin, AM
    Beatch, GN
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (12) : 2355 - 2361
  • [8] Vernakalant hydrochloride for rapid conversion of atrial fibrillation - A phase 3, randomized, placebo-controlled trial
    Roy, Denis
    Pratt, Craig M.
    Torp-Pedersen, Christian
    Wyse, D. George
    Toft, Egon
    Juul-Moller, Steen
    Nielsen, Tonny
    Rasmussen, S. Lind
    Stiell, Ian G.
    Coutu, Benoit
    Ip, John H.
    Pritchett, Edward L. C.
    Camm, A. John
    [J]. CIRCULATION, 2008, 117 (12) : 1518 - 1525